Adapting versatile
polymers to improve
surgical outcomes
and patient recovery

About Us

Polyganics is a medical technology company which develops, manufactures and commercializes innovative bioresorbable medical devices that facilitate natural tissue repair and regeneration after surgery.

Latest News

Apr 20, 2017

Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study

read more

Feb 16, 2017

Polyganics’ “STOP NEUROMA” Study Interim Data Shows Reduction in Pain

read more

Dec 07, 2016

Polyganics announces Birmingham Hand Centre efficacy study of nerve conduit NEUROLAC® in finger surgery

read more

View all news →


Polyganics’ leadership team has a proven track record of successfully running medical technology companies. The team is highly experienced across all technical, operational and financial aspects as well as creating strategic alliances with industry partners.

Rudy Mareel

CEO (a.i.)

Romke Ribbels

Director Marketing & Business Development

Raoul Beex

International Sales Director

Bart-Jan Korteling

Director Research & Product Development